Stock vs Stock Comparison

Intuitive Surgical, Inc. vs Abbott Laboratories

ISRG wins the Tale of the Tape 7–2.

ISRG$407.29
ABT$86.99

🏆 Tale of the Tape

72
ISRGABT
28.4%Profitability (Net Margin)14.7%
51.5xValuation (P/E)24.0x
12.6%Efficiency (ROIC)10.1%
7/9Health (Piotroski F)5/9
40.1Safety (Altman Z)4.9
20.5%Growth (Rev YoY)5.7%
-0.47Risk (Sharpe 1Y)-1.05
0.14xBalance Sheet (D/E)0.64x
1.59%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.153
252-Day Correlation
0.153
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricISRGABT
Market Cap$150.4B$149.1B
P/E Ratio51.5x24.0x
Forward P/E36.0x14.1x
P/B8.61x2.86x
Dividend Yield2.94%
Beta1.510.65

Quantitative Metrics

MetricISRGABT
DCF Fair Value$257.36$57.20
DCF Upside-43.9%-43.2%
Piotroski F7/95/9
Altman Z40.054.87
Beneish M-2.47-2.53
FCF Yield1.59%4.21%
Net Debt/EBITDA0.1x
ROIC12.6%10.1%
WACC9.4%
ROIC – WACC0.7pp
Gross Margin66.0%56.4%
Net Margin28.4%14.7%
Rev Growth YoY20.5%5.7%
Sharpe (1Y)-0.47-1.05
Max Drawdown 3Y
FCF Payout Ratio56%

ISRG Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

ISRG found in:

IHI16.53%
BOTZ5.81%
IYH2.96%
XLV2.91%
VHT2.63%
XHE1.52%
ARKQ1.23%
QQQ1.10%
MGK0.72%
SCHG0.68%
IWF0.59%
VONG0.52%
VUG0.48%
SPYG0.45%
IVV0.34%
ESGV0.33%
SPLG0.33%
QUS0.31%
ITOT0.30%
SCHX0.29%
SCHB0.27%
VOO0.26%
VONE0.25%
SPY0.24%
VTI0.23%
SPTM0.22%
URTH0.21%
ACWI0.19%
RSP0.18%
VT0.14%
ONEO0.04%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ISRG vs ABT: Head-to-Head Analysis

Intuitive Surgical, Inc. (ISRG) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ISRG leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ISRG generates a return on invested capital (ROIC) of 12.6% compared to ABT's 10.1%. This suggests ISRG is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ISRG and ABT is 0.153, indicating low correlation, making them an effective diversification pair in a portfolio context.

ISRG appears in 31 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ISRG or ABT?

Our quantitative analysis compares ISRG and ABT across nine fundamental dimensions. ISRG wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ISRG and ABT correlated?

The 252-day correlation between ISRG and ABT is 0.153. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.